Статья
Клинический случай очень позднего тромбоза биолимус-выделяющего коронарного стента
Представлен клинический случай развития очень позднего тромбоза биолимус-выделяющего стента передней нисходящей артерии, обсуждаются факторы риска и возможные пути профилактики развития данного осложнения.
1. Claessen BE, Henriques JPS, Jaffer FA, Mehran R, Piek JJ, Dangas GD. Stent Thrombosis. JACC: Cardiovascular Interventions. 2014;7(10):1081–92. DOI: 10.1016/j.jcin.2014.05.016
2. Ганюков В. И., Шилов А. А., Бохан Н. С., Моисеенков Г. В., Барбараш Л. С. Причины тромбозов стентов коронарных артерий. Международный журнал интервенционной кардиоангиологии. 2011;(27–28):29–34.
3. Honda T, Fujimoto K, Miyao Y, Koga H, Ishii M. Current cigarette smoking is an independent risk factor for subacute stent thrombosis in acute myocardial infarction patients. Journal of Cardiology. 2014;63(5):358–64. DOI: 10.1016/j.jjcc.2013.10.007
4. Schmiegelow M, Torp-Pedersen C, Gislason GH, Andersson C, Lyngbæk S, Pedersen S et al. Relation of Body Mass Index to Risk of Stent Thrombosis After Percutaneous Coronary Intervention. The American Journal of Cardiology. 2012;110(11):1592–7. DOI: 10.1016/j.amjcard.2012.07.029
5. Palmerini T, Biondi-Zoccai G, Stone GW. Stent selection to minimize the risk of stent thrombosis: Current Opinion in Cardiology. 2014;29(6):578–85. DOI: 10.1097/HCO.0000000000000102
6. Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. JACC. Cardiovascular interventions. 2013;6(12):1267–74. DOI: 10.1016/j.jcin.2013.06.015
7. Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG et al. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. JACC: Cardiovascular Interventions. 2015;8(12):1552–62. DOI: 10.1016/j.jcin.2015.05.026
8. Armstrong EJ, Sab S, Singh GD, Lim W, Yeo K-K, Waldo SW et al. Predictors and Outcomes of Recurrent Stent Thrombosis. JACC: Cardiovascular Interventions. 2014;7(10):1105–13. DOI: 10.1016/j. jcin.2014.05.017
9. Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H et al. Development and Validation of a Stent Th ombosis Risk Score in Patients with Acute Coronary Syndromes. JACC: Cardiovascular Interventions. 2012;5(11):1097–105. DOI: 10.1016/j.jcin.2012.07.012
10. Centemero MP, Stadler JR. Stent thrombosis: an overview. Expert Review of Cardiovascular Therapy. 2012;10(5):599–615. DOI: 10.1586/erc.12.38
11. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119–77. DOI: 10.1093/eurheartj/ehx393
12. Lotfi A, Reejhsinghani R. Prevention of stent thrombosis: challenges and solutions. Vascular Health and Risk Management. 2015;93. DOI: 10.2147/VHRM.S43357
13. Cai Z, Shen L, He B. Moving with and beyond CANTOS: How to put out the fire of inflammation in atherosclerosis? International Journal of Cardiology. 2015;195:45–7. DOI: 10.1016/j.ijcard.2015.05.123
14. Ridker PM, Thuren T, Zalewski A, Libby P. Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Th ombosis Outcomes Study (CANTOS). American Heart Journal. 2011;162(4):597–605. DOI: 10.1016/j.ahj.2011.06.012
15. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal. 2016;37(3):267–315. DOI: 10.1093/eurheartj/ehv320